News
Press Center
Boehringer Ingelheim has concluded phase one of their localization effort aimed at manufacturing their innovative thrombolytic medicines in Russia: the first batches of Metalyse (tenectaplase) for acute heart attack treatment were produced at NPO Petrovax Pharm facilities.
More
Topics Petrovax Pharm According to Rosa Khutor general Director Sergey Bachin, «in 2015 winter season, Rosa Khutor hosted 600 thousand tourists and 750 thousand in summer season, this gives us a total of 1.35 mln guests in 2015. In 2016 winter season, the number of visitors reached 800 thousand, it’s a 30% increase compared to the previous winter season. We expect that in 2016 the total number of tourists will reach 1.5 mln».
More
Topics Rosa Khutor